204 related articles for article (PubMed ID: 14997460)
1. [Homocysteine and cerebrovascular disease].
Sepúlveda-Sánchez JM; Matía-Francés R; Martínez-Salio A; González-de la Aleja-Tejera J; Rodríguez-Peña Marín M; Porta-Etessam J
Rev Neurol; 2004 Feb 16-29; 38(4):347-58. PubMed ID: 14997460
[TBL] [Abstract][Full Text] [Related]
2. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
3. Ischemic stroke and hyperhomocysteinemia: truth or myth?
Terwecoren A; Steen E; Benoit D; Boon P; Hemelsoet D
Acta Neurol Belg; 2009 Sep; 109(3):181-8. PubMed ID: 19902811
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia and venous thrombosis.
Gatt A; Makris M
Semin Hematol; 2007 Apr; 44(2):70-6. PubMed ID: 17433898
[TBL] [Abstract][Full Text] [Related]
5. [Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?].
Méndez-González J; Rodríguez-Millán E; Julve J; Blanco-Vaca F
Rev Neurol; 2010 Feb 16-28; 50(4):235-44. PubMed ID: 20198596
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine: evidence for a causal relationship with cardiovascular disease.
Scott CH; Sutton MS
Cardiol Rev; 1999; 7(2):101-7. PubMed ID: 10348972
[TBL] [Abstract][Full Text] [Related]
7. [Factors determining hyperhomocysteinemia in the chronic phase of strokes].
Carod-Artal FJ; Nunes SV; Vargas AP; Portugal D
Rev Neurol; 2007 May 1-15; 44(9):513-9. PubMed ID: 17492607
[TBL] [Abstract][Full Text] [Related]
8. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
[TBL] [Abstract][Full Text] [Related]
9. [The plasma homocysteine, folic acid and vitamin B12 levels in young people with high risk for cardiovascular disease and its relation to metylentetrahydrofolate reductase (MTHFR) gene polymorphism].
Klujber V; Lengyel B; Szabó T; Németh A; Dobó M
Orv Hetil; 2005 Apr; 146(14):649-51. PubMed ID: 15889539
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine, B-vitamins and CVD.
McNulty H; Pentieva K; Hoey L; Ward M
Proc Nutr Soc; 2008 May; 67(2):232-7. PubMed ID: 18412997
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
[TBL] [Abstract][Full Text] [Related]
15. [Group B vitamins as new variables related to the cardiovascular risk].
Granieri M; Bellisarii FI; De Caterina R
Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
[TBL] [Abstract][Full Text] [Related]
16. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
Dinleyici EC; Kirel B; Alatas O; Muslumanoglu H; Kilic Z; Dogruel N
J Trop Pediatr; 2006 Aug; 52(4):260-6. PubMed ID: 16401615
[TBL] [Abstract][Full Text] [Related]
17. [Homocysteine. The cardiovascular risk factor of the next millennium?].
Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
[TBL] [Abstract][Full Text] [Related]
18. Genetic determinants of plasma total homocysteine.
Gellekink H; den Heijer M; Heil SG; Blom HJ
Semin Vasc Med; 2005 May; 5(2):98-109. PubMed ID: 16047263
[TBL] [Abstract][Full Text] [Related]
19. New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism.
De Caterina R; Zampolli A; Madonna R; Fioretti P; Vanuzzo D
Ital Heart J; 2004 Jun; 5 Suppl 6():19S-24S. PubMed ID: 15185912
[TBL] [Abstract][Full Text] [Related]
20. [The role of hyper-homocysteinemia in the etiology of some vascular diseases].
Czeizel E; Matos L
Orv Hetil; 1998 Sep; 139(37):2191-6. PubMed ID: 9769688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
